PF-06409577 (Standard)
PF-06409577 (Standard) is the analytical standard of PF-06409577. This product is intended for research and analytical applications. PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 1467057-23-3
- Formule: C19H16ClNO3
- Masse moléculaire:341.79
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-103683
PF-06409577AMPK Activator -
HY-50662
A-769662AMPK Activator -
HY-112769
EX229AMPK Activator -
HY-12357
Bempedoic acidACL Inhibitor/AMPK Activator -
HY-13417
AICARAMPK Activator -
HY-13418A
DorsomorphinAMPK Inhibitor -
HY-112233
O-304AMPK Activator -
HY-B0627
MetforminAntihyperglycemic Agent -
HY-100548
GSK621AMPK Activator -
HY-111363
MK8722AMPK Activator -
HY-13418
Dorsomorphin dihydrochlorideAMPK Inhibitor -
HY-107988
MK-3903AMPK Activator
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1467057-23-3
-
Masse moléculaire 341.79
-
Formule C19H16ClNO3
-
SMILES
O=C(C1=CNC2=C1C=C(C3=CC=C(C4(O)CCC4)C=C3)C(Cl)=C2)O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Cameron KO, et al. Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy. J Med Chem. 2016 Sep 8;59(17):8068-81. [Content Brief]
[2]. Salatto CT, et al. Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy. J Pharmacol Exp Ther. 2017 May;361(2):303-311. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PF-06409577 (Standard) Related Classifications
HY-103683R Related Classifications
Powered by Bioz